Olympus Korea will discontinue its camera business on June 30 due to low profitability and will shift its focus on medical equipment and science solutions.
The Korean unit of the Japan-headquartered firm that makes optics and photography products will also close its store and online shopping mall next month.
Olympus Korea will keep operating the service facility for repairing and exchanging products until March 31, 2026.
The company tried to improve its profitability with mirrorless cameras and interchangeable lenses, but as South Korea's camera market shrank considerably, it had to withdraw from the business.
Among Olympus Korea's other offerings are endoscopy and surgical equipment and microscopes.
The company has a medical training and education center in Incheon, which it opened in 2017.
Olympus Korea denied that their decision is in support of an ongoing anti-Japan sentiment and boycott all Japanese products in South Korea.


Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline 



